India  
 
NewsR.in

Ask Dr. Nandi: FDA wants two months of safety data before considering COVID-19 vaccine

Video Credit: WXYZ Detroit - Duration: 03:13s - Published
Ask Dr. Nandi: FDA wants two months of safety data before considering COVID-19 vaccine

Ask Dr. Nandi: FDA wants two months of safety data before considering COVID-19 vaccine

There are new FDA guidelines for coronavirus vaccine developers.

Two months of follow-up data on volunteers in phase 3 trials are now needed before Emergency Use Authorization will be considered.


You Might Like


Related videos from verified sources

Dr. Oz Asks About Guidelines That Require Drug Manufacturers Follow Clinical Trial Participants For At Least Two Months [Video]

Dr. Oz Asks About Guidelines That Require Drug Manufacturers Follow Clinical Trial Participants For At Least Two Months

Dr. Oz asks Dr. Hotez about the FDA’s new guidelines that require drug manufacturers to follow clinical trial participants for at least two months, and how that will affect vaccine development.

Credit: CBS 62 Detroit     Duration: 00:39Published
COVID-19 vaccine not possible before election [Video]

COVID-19 vaccine not possible before election

The need for the FDA to follow those who received a vaccine for two months could push back the vaccine rollouts until after the election.

Credit: FOX 4 Now Florida     Duration: 02:14Published
The White House blocks new FDA guidelines [Video]

The White House blocks new FDA guidelines

The White House has blocked new guidelines from the FDA that could have made COVID-19 vaccines safer. The agency wanted vaccine developers to follow trial participants for two months after they..

Credit: KTNV Channel 13 Las Vegas     Duration: 00:25Published